Results of comprehensive molecular profiling of gliomas and the potential therapeutic implications


Santosh Kesari, Joanne Xiu, David B. Spetzler, Anatole Ghazalpour, Zoran Gatalica, Nader Sanai


Gliomas are the most common type of primary brain tumors with underlying molecular heterogeneity contributing to differential treatment response. Our retrospective study was designed to interrogate biomarkers from a large cohort of glioma patients to identify alterations with therapeutic implications.

Download Publication